Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Foley Viewpoints

    Patenting Risk Evaluation & Mitigation Strategies; For Pharmaceuticals: A New Life Cycle Management Target for Patents?

    January 2, 2009

    Author(s)

    Stephen B. Maebius

    Washington, D.C. 202.672.5569

    David L. Rosen

    Washington, D.C. 202.672.5430

    Judith A. Waltz

    San Francisco 415.438.6412

    Related Insights

    View All Posts
    June 6, 2025 Energy Current

    House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas

    On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
    June 23, 2025 Events

    Third Annual Transaction Solutions Symposium 

    Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
    June 5, 2025 Health Care Law Today

    GLP-1 Compounded Medications Targeted by Connecticut Attorney General

    On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding  allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.